-
1
-
-
0028864991
-
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion
-
Jung, HC, Eckmann, L, Yang, SK, Panja, A, Fierer, J, Morzycka-Wroblewska, E et al. (1995). A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95: 55-65.
-
(1995)
J Clin Invest
, vol.95
, pp. 55-65
-
-
Jung, H.C.1
Eckmann, L.2
Yang, S.K.3
Panja, A.4
Fierer, J.5
Morzycka-Wroblewska, E.6
-
2
-
-
0031573593
-
A Role for TNF-α and Mucosal T Helper-1 Cytokines in the Pathogenesis of Crohn's Disease
-
Plevy, SE, Landers, CJ, Prehn, J, Carramanzana, NM, Deem, RL, Shealy, D et al. (1997). A role for TNF-and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 159: 6276-6282. (Pubitemid 127471570)
-
(1997)
Journal of Immunology
, vol.159
, Issue.12
, pp. 6276-6282
-
-
Plevy, S.E.1
Landers, C.J.2
Prehn, J.3
Carramanzana, N.M.4
Deem, R.L.5
Shealy, D.6
Targan, S.R.7
-
3
-
-
0030981088
-
Tumour necrosis factor and Crohn's disease
-
Van Deventer, SJ (1997). Tumour necrosis factor and Crohn's disease. Gut 40: 443-448. (Pubitemid 27204920)
-
(1997)
Gut
, vol.40
, Issue.4
, pp. 443-448
-
-
Van Deventer, S.J.H.1
-
4
-
-
0034005581
-
Role of cytokines in the pathogenesis of inflammatory bowel disease
-
DOI 10.1146/annurev.med.51.1.289
-
Papadakis, KA and Targan, SR (2000). Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51: 289-298. (Pubitemid 30216038)
-
(2000)
Annual Review of Medicine
, vol.51
, pp. 289-298
-
-
Papadakis, K.A.1
Targan, S.R.2
-
5
-
-
0032861577
-
A soluble factor produced by lamina propria mononuclear cells is required for TNF-α enhancement of IFN-γ production by T cells
-
Prehn, JL, Landers, CJ and Targan, SR (1999). A soluble factor produced by lamina propria mononuclear cells is required for TNF-enhancement of IFN-production by T cells. J Immunol 163: 4277-4283. (Pubitemid 29474493)
-
(1999)
Journal of Immunology
, vol.163
, Issue.8
, pp. 4277-4283
-
-
Prehn, J.L.1
Landers, C.J.2
Targan, S.R.3
-
6
-
-
0031972742
-
Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis
-
DOI 10.1159/000007470
-
Funakoshi, K, Sugimura, K, Anezaki, K, Bannai, H, Ishizuka, K and Asakura, H (1998). Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis. Digestion 59: 73-78. (Pubitemid 28022450)
-
(1998)
Digestion
, vol.59
, Issue.1
, pp. 73-78
-
-
Funakoshi, K.1
Sugimura, K.2
Anezaki, K.3
Bannai, H.4
Ishizuka, K.5
Asakura, H.6
-
7
-
-
0034956578
-
Tumor necrosis factor-α in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR
-
Komatsu, M, Kobayashi, D, Saito, K, Furuya, D, Yagihashi, A, Araake, H et al. (2001). Tumor necrosis factor-αin serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem 47: 1297-1301. (Pubitemid 32579119)
-
(2001)
Clinical Chemistry
, vol.47
, Issue.7
, pp. 1297-1301
-
-
Komatsu, M.1
Kobayashi, D.2
Saito, K.3
Furuya, D.4
Yagihashi, A.5
Araake, H.6
Tsuji, N.7
Sakamaki, S.8
Niitsu, Y.9
Watanabe, N.10
-
8
-
-
0027486125
-
Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease
-
Murch, SH, Braegger, CP, Walker-Smith, JA and MacDonald, TT (1993). Location of tumour necrosis factor by immunohistochemistry in chronic inflammatory bowel disease. Gut 34: 1705-1709. (Pubitemid 23353163)
-
(1993)
Gut
, vol.34
, Issue.12
, pp. 1705-1709
-
-
Murch, S.H.1
Braegger, C.P.2
Walker-Smith, J.A.3
MacDonald, T.T.4
-
9
-
-
0033031021
-
Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease
-
Woywodt, A, Ludwig, D, Neustock, P, Kruse, A, Schwarting, K, Jantschek, G et al. (1999). Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 11: 267-276. (Pubitemid 29286680)
-
(1999)
European Journal of Gastroenterology and Hepatology
, vol.11
, Issue.3
, pp. 267-276
-
-
Woywodt, A.1
Ludwig, D.2
Neustock, P.3
Kruse, A.4
Schwarting, K.5
Jantschek, G.6
Kirchner, H.7
Stange, E.F.8
-
10
-
-
0028006855
-
Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
-
Dieleman, LA, Ridwan, BU, Tennyson, GS, Beagley, KW, Bucy, RP and Elson, CO (1994). Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107: 1643-1652. (Pubitemid 24357616)
-
(1994)
Gastroenterology
, vol.107
, Issue.6
, pp. 1643-1652
-
-
Dieleman, L.A.1
Ridwan, B.U.2
Tennyson, G.S.3
Beagley, K.W.4
Bucy, R.P.5
Elson, C.O.6
-
11
-
-
0030818051
-
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
-
DOI 10.1002/eji.1830270722
-
Neurath, MF, Fuss, I, Pasparakis, M, Alexopoulou, L, Haralambous, S, Meyer zum Büschenfelde, KH et al. (1997). Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27: 1743-1750. (Pubitemid 27302858)
-
(1997)
European Journal of Immunology
, vol.27
, Issue.7
, pp. 1743-1750
-
-
Neurath, M.F.1
Fuss, I.2
Pasparakis, M.3
Alexopoulou, L.4
Haralambous, S.5
Meyer Zum Buschenfelde, K.-H.6
Strober, W.7
Kollias, G.8
-
12
-
-
0034526788
-
Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-α
-
Gitter, AH, Bendfeldt, K, Schmitz, H, Schulzke, JD, Bentzel, CJ and Fromm, M (2000). Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-?. Ann N Y Acad Sci 915: 193-203. (Pubitemid 32059380)
-
(2000)
Annals of the New York Academy of Sciences
, vol.915
, pp. 193-203
-
-
Gitter, A.H.1
Bendfeldt, K.2
Schmitz, H.3
Schulzke, J.-D.4
Bentzel, C.J.5
Fromm, M.6
-
13
-
-
0032005048
-
Tumor necrosis factor-α increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line
-
DOI 10.1007/s002329900333
-
Marano, CW, Lewis, SA, Garulacan, LA, Soler, AP and Mullin, JM (1998). Tumor necrosis factor-αincreases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol 161: 263-274. (Pubitemid 28085051)
-
(1998)
Journal of Membrane Biology
, vol.161
, Issue.3
, pp. 263-274
-
-
Marano, C.W.1
Lewis, S.A.2
Garulacan, L.A.3
Peralta Soler, A.4
Mullin, J.M.5
-
14
-
-
84856549297
-
Cytokines and cell homeostasis in the gastrointestinal tract
-
Böcker, U (2000). Cytokines and cell homeostasis in the gastrointestinal tract. Lancaster.
-
(2000)
Lancaster
-
-
Böcker, U.1
-
15
-
-
0037215607
-
Antisense oligonucleotide blockade of tumor necrosis factorα in two murine models of colitis
-
DOI 10.1124/jpet.102.040329
-
Myers, KJ, Murthy, S, Flanigan, A, Witchell, DR, Butler, M, Murray, S et al. (2003). Antisense oligonucleotide blockade of tumor necrosis factor-αin two murine models of colitis. J Pharmacol Exp Ther 304: 411-424. (Pubitemid 36008955)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.304
, Issue.1
, pp. 411-424
-
-
Myers, K.J.1
Murthy, S.2
Flanigan, A.3
Witchell, D.R.4
Butler, M.5
Murray, S.6
Siwkowski, A.7
Goodfellow, D.8
Madsen, K.9
Baker, B.10
-
16
-
-
0028519015
-
Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
-
Powrie, F, Leach, MW, Mauze, S, Menon, S, Caddle, LB and Coffman, RL (1994). Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553-562.
-
(1994)
Immunity
, vol.1
, pp. 553-562
-
-
Powrie, F.1
Leach, M.W.2
Mauze, S.3
Menon, S.4
Caddle, L.B.5
Coffman, R.L.6
-
17
-
-
0033957727
-
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice
-
Hartmann, G, Bidlingmaier, C, Siegmund, B, Albrich, S, Schulze, J, Tschoep, K et al. (2000). Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J Pharmacol Exp Ther 292: 22-30. (Pubitemid 30026352)
-
(2000)
Journal of Pharmacology and Experimental Therapeutics
, vol.292
, Issue.1
, pp. 22-30
-
-
Hartmann, G.1
Bidlingmaier, C.2
Siegmund, B.3
Albrich, S.4
Schulze, J.5
Tschoep, K.6
Eigler, A.7
Lehr, H.A.8
Endres, S.9
-
18
-
-
0035846326
-
Tuberculosis associated with infliximab, a tumor necrosis factor-neutralizing agent
-
Keane, J, Gershon, S, Wise, RP, Mirabile-Levens, E, Kasznica, J, Schwieterman, WD et al. (2001). Tuberculosis associated with infliximab, a tumor necrosis factor-neutralizing agent. N Engl J Med 345: 1098-1104.
-
(2001)
N Engl J Med
, vol.345
, pp. 1098-1104
-
-
Keane, J.1
Gershon, S.2
Wise, R.P.3
Mirabile-Levens, E.4
Kasznica, J.5
Schwieterman, W.D.6
-
19
-
-
0033125226
-
Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
-
Sandborn, WJ and Hanauer, SB (1999). Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 5: 119-133.
-
(1999)
Inflamm Bowel Dis
, vol.5
, pp. 119-133
-
-
Sandborn, W.J.1
Hanauer, S.B.2
-
20
-
-
0036900501
-
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration
-
DOI 10.1002/art.10679
-
Brown, SL, Greene, MH, Gershon, SK, Edwards, ET and Braun, MM (2002). Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46: 3151-3158. (Pubitemid 35453523)
-
(2002)
Arthritis and Rheumatism
, vol.46
, Issue.12
, pp. 3151-3158
-
-
Brown, S.L.1
Greene, M.H.2
Gershon, S.K.3
Edwards, E.T.4
Braun, M.M.5
-
21
-
-
77950792860
-
Targeting delivery of anti-TNF αoligonucleotide into activated colonic macrophages protects against experimental colitis
-
Zuo, L, Huang, Z, Dong, L, Xu, L, Zhu, Y, Zeng, K et al. (2010). Targeting delivery of anti-TNF αoligonucleotide into activated colonic macrophages protects against experimental colitis. Gut 59: 470-479.
-
(2010)
Gut
, vol.59
, pp. 470-479
-
-
Zuo, L.1
Huang, Z.2
Dong, L.3
Xu, L.4
Zhu, Y.5
Zeng, K.6
-
22
-
-
0035117939
-
Efficacy of adenoviral TNFα antisense is enhanced by a macrophage specific promoter
-
DOI 10.1038/sj.gt.3301368
-
Sidiropoulos, P, Liu, H, Mungre, S, Anderson, L, Thimmapaya, B and Pope, RM (2001). Efficacy of adenoviral TNF antisense is enhanced by a macrophage specific promoter. Gene Ther 8: 223-231. (Pubitemid 32186134)
-
(2001)
Gene Therapy
, vol.8
, Issue.3
, pp. 223-231
-
-
Sidiropoulos, P.1
Liu, H.2
Mungre, S.3
Anderson, L.4
Thimmapaya, B.5
Pope, R.M.6
-
23
-
-
0032989151
-
The clinical experience of antisense therapy to ICAM-1 in Crohn's disease
-
Yacyshyn, B, Bowen-Yacyshyn, MB and Shanahan, W (1999). The clinical experience of antisense therapy to ICAM-1 in Crohn's disease. Curr Opin Mol Ther 1: 332-335. (Pubitemid 29309181)
-
(1999)
Current Opinion in Molecular Therapeutics
, vol.1
, Issue.3
, pp. 332-335
-
-
Yacyshyn, B.1
Bowen-Yacyshyn, M.B.2
Shanahan, W.3
-
24
-
-
1942533474
-
In vivo activity of nuclease-resistant siRNAs
-
DOI 10.1261/rna.5239604
-
Layzer, JM, McCaffrey, AP, Tanner, AK, Huang, Z, Kay, MA and Sullenger, BA (2004). In vivo activity of nuclease-resistant siRNAs. RNA 10: 766-771. (Pubitemid 38529739)
-
(2004)
RNA
, vol.10
, Issue.5
, pp. 766-771
-
-
Layzer, J.M.1
McCaffrey, A.P.2
Tanner, A.K.3
Huang, Z.4
Kay, M.A.5
Sullenger, B.A.6
-
25
-
-
79951955176
-
Oral TNF-A gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease
-
Kriegel, C and Amiji, M (2011). Oral TNF-a gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease. J Control Release 150: 77-86.
-
(2011)
J Control Release
, vol.150
, pp. 77-86
-
-
Kriegel, C.1
Amiji, M.2
-
26
-
-
0141552295
-
Gene silencing by systemic delivery of synthetic siRNAs in adult mice
-
DOI 10.1016/S0022-2836(03)00181-5
-
Sørensen, DR, Leirdal, M and Sioud, M (2003). Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 327: 761-766. (Pubitemid 36315917)
-
(2003)
Journal of Molecular Biology
, vol.327
, Issue.4
, pp. 761-766
-
-
Sorensen, D.R.1
Leirdal, M.2
Sioud, M.3
-
27
-
-
84988077143
-
Conjugation of oligonucleotides to 3'-polar moieties
-
Aerschot, AS-BT, Rozenski, J, Hendrix, C, Schepers, D, Verhoeven, G, and Herdewijn, P (1995). Conjugation of oligonucleotides to 3'-polar moieties. Bull Soc Chim Belg 104: 717-720.
-
(1995)
Bull Soc Chim Belg
, vol.104
, pp. 717-720
-
-
As-Bt, A.1
Rozenski, J.2
Hendrix, C.3
Schepers, D.4
Verhoeven, G.5
Herdewijn, P.6
-
28
-
-
74049124186
-
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
-
Jackson, AL and Linsley, PS (2010). Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9: 57-67.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 57-67
-
-
Jackson, A.L.1
Linsley, P.S.2
-
29
-
-
4444361558
-
Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form
-
DOI 10.1053/j.gastro.2004.06.036, PII S0016508504011540
-
Corazza, N, Brunner, T, Buri, C, Rihs, S, Imboden, MA, Seibold, I et al. (2004). Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form. Gastroenterology 127: 816-825. (Pubitemid 39208414)
-
(2004)
Gastroenterology
, vol.127
, Issue.3
, pp. 816-825
-
-
Corazza, N.1
Brunner, T.2
Buri, C.3
Rihs, S.4
Imboden, M.A.5
Seibold, I.6
Mueller, C.7
-
30
-
-
33746913567
-
Engineering Mucosal RNA Interference in Vivo
-
DOI 10.1016/j.ymthe.2006.04.001, PII S1525001606001389
-
Zhang, Y, Cristofaro, P, Silbermann, R, Pusch, O, Boden, D, Konkin, T et al. (2006). Engineering mucosal RNA interference in vivo. Mol Ther 14: 336-342. (Pubitemid 44184961)
-
(2006)
Molecular Therapy
, vol.14
, Issue.3
, pp. 336-342
-
-
Zhang, Y.1
Cristofaro, P.2
Silbermann, R.3
Pusch, O.4
Boden, D.5
Konkin, T.6
Hovanesian, V.7
Monfils, P.R.8
Resnick, M.9
Moss, S.F.10
Ramratnam, B.11
-
31
-
-
84856525489
-
Antisense oligonucleotides as anticancer agents
-
Herdewijn, P, Saison-Behmoaras, E, Van Aerschot, A, Leserman, L, Eritja, R and Pfleiderer, W (1998). Antisense oligonucleotides as anticancer agents. Biomedical and Health Research 24: 182-189.
-
(1998)
Biomedical and Health Research
, vol.24
, pp. 182-189
-
-
Herdewijn, P.1
Saison-Behmoaras, E.2
Van Aerschot, A.3
Leserman, L.4
Eritja, R.5
Pfleiderer, W.6
-
32
-
-
0026175462
-
Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma
-
Eder, PS, DeVine, RJ, Dagle, JM and Walder, JA (1991). Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. Antisense Res Dev 1: 141-151.
-
(1991)
Antisense Res Dev
, vol.1
, pp. 141-151
-
-
Eder, P.S.1
Devine, R.J.2
Dagle, J.M.3
Walder, J.A.4
-
33
-
-
0028876462
-
Antiserum to tumor necrosis factor and failure to prevent murine colitis
-
Olson, AD, DelBuono, EA, Bitar, KN and Remick, DG (1995). Antiserum to tumor necrosis factor and failure to prevent murine colitis. J Pediatr Gastroenterol Nutr 21: 410-418.
-
(1995)
J Pediatr Gastroenterol Nutr
, vol.21
, pp. 410-418
-
-
Olson, A.D.1
Delbuono, E.A.2
Bitar, K.N.3
Remick, D.G.4
-
34
-
-
0031015257
-
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice
-
Kojouharoff, G, Hans, W, Obermeier, F, Männel, DN, Andus, T, Schölmerich, J et al. (1997). Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107: 353-358. (Pubitemid 27049264)
-
(1997)
Clinical and Experimental Immunology
, vol.107
, Issue.2
, pp. 353-358
-
-
Kojouharoff, G.1
Hans, W.2
Obermeler, F.3
Mannel, D.N.4
Andus, T.5
Scholmerich, J.6
Gross, V.7
Falk, W.8
-
35
-
-
77952318710
-
TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis
-
Noti, M, Corazza, N, Mueller, C, Berger, B and Brunner, T (2010). TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis. J Exp Med 207: 1057-1066.
-
(2010)
J Exp Med
, vol.207
, pp. 1057-1066
-
-
Noti, M.1
Corazza, N.2
Mueller, C.3
Berger, B.4
Brunner, T.5
-
36
-
-
0038730729
-
Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice
-
DOI 10.1046/j.1440-1746.2003.03034.x
-
Naito, Y, Takagi, T, Handa, O, Ishikawa, T, Nakagawa, S, Yamaguchi, T et al. (2003). Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-αdeficient mice. J Gastroenterol Hepatol 18: 560-569. (Pubitemid 36645291)
-
(2003)
Journal of Gastroenterology and Hepatology
, vol.18
, Issue.5
, pp. 560-569
-
-
Naito, Y.1
Takagi, T.2
Handa, O.3
Ishikawa, T.4
Nakagawa, S.5
Yamaguchi, T.6
Yoshida, N.7
Minami, M.8
Kita, M.9
Imanishi, J.10
Yoshikawa, T.11
-
37
-
-
0035910751
-
Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination
-
DOI 10.1084/jem.193.4.427
-
Kassiotis, G and Kollias, G (2001). Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 193: 427-434. (Pubitemid 32524474)
-
(2001)
Journal of Experimental Medicine
, vol.193
, Issue.4
, pp. 427-434
-
-
Kassiotis, G.1
Kollias, G.2
-
38
-
-
34250628479
-
Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate
-
Suzuki, R, Miyamoto, S, Yasui, Y, Sugie, S and Tanaka, T (2007). Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate. BMC Cancer 7: 84.
-
(2007)
BMC Cancer
, vol.7
, pp. 84
-
-
Suzuki, R.1
Miyamoto, S.2
Yasui, Y.3
Sugie, S.4
Tanaka, T.5
-
39
-
-
10844255792
-
CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis
-
DOI 10.1136/gut.2003.029587
-
Gao, D, Wagner, AH, Fankhaenel, S, Stojanovic, T, Schweyer, S, Panzner, S et al. (2005). CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis. Gut 54: 70-77. (Pubitemid 40007220)
-
(2005)
Gut
, vol.54
, Issue.1
, pp. 70-77
-
-
Gao, D.1
Wagner, A.H.2
Fankhaenel, S.3
Stojanovic, T.4
Schweyer, S.5
Panzner, S.6
Hecker, M.7
-
40
-
-
34547638394
-
Activation of toll-like receptor 3 protects against DSS-induced acute colitis
-
DOI 10.1002/ibd.20142
-
Vijay-Kumar, M, Wu, H, Aitken, J, Kolachala, VL, Neish, AS, Sitaraman, SV et al. (2007). Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis 13: 856-864. (Pubitemid 47203863)
-
(2007)
Inflammatory Bowel Diseases
, vol.13
, Issue.7
, pp. 856-864
-
-
Vijay-Kumar, M.1
Wu, H.2
Aitken, J.3
Kolachala, V.L.4
Neish, A.5
Sitaraman, S.V.6
Gewirtz, A.T.7
-
41
-
-
33751511117
-
Gene Expression Analysis in Blood Cells in Response to Unmodified and 2′-Modified siRNAs Reveals TLR-dependent and Independent Effects
-
DOI 10.1016/j.jmb.2006.09.034, PII S0022283606012253
-
Cekaite, L, Furset, G, Hovig, E and Sioud, M (2007). Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects. J Mol Biol 365: 90-108. (Pubitemid 44830036)
-
(2007)
Journal of Molecular Biology
, vol.365
, Issue.1
, pp. 90-108
-
-
Cekaite, L.1
Furset, G.2
Hovig, E.3
Sioud, M.4
-
42
-
-
33644620908
-
Chemical modification of siRNAs to improve serum stability without loss of efficacy
-
DOI 10.1016/j.bbrc.2006.02.049, PII S0006291X06003366
-
Choung, S, Kim, YJ, Kim, S, Park, HO and Choi, YC (2006). Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun 342: 919-927. (Pubitemid 43320485)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.342
, Issue.3
, pp. 919-927
-
-
Choung, S.1
Kim, Y.J.2
Kim, S.3
Park, H.-O.4
Choi, Y.-C.5
-
43
-
-
34548108038
-
2′-O-methyl-modified RNAs act as TLR7 antagonists
-
DOI 10.1038/sj.mt.6300240, PII 6300240
-
Robbins, M, Judge, A, Liang, L, McClintock, K, Yaworski, E and MacLachlan, I (2007). 2'-O-methyl-modified RNAs act as TLR7 antagonists. Mol Ther 15: 1663-1669. (Pubitemid 47289010)
-
(2007)
Molecular Therapy
, vol.15
, Issue.9
, pp. 1663-1669
-
-
Robbins, M.1
Judge, A.2
Liang, L.3
McClintock, K.4
Yaworski, E.5
MacLachlan, I.6
-
44
-
-
23844464444
-
Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA
-
DOI 10.1016/j.immuni.2005.06.008, PII S1074761305002116
-
Karikó, K, Buckstein, M, Ni, H and Weissman, D (2005). Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23: 165-175. (Pubitemid 41169286)
-
(2005)
Immunity
, vol.23
, Issue.2
, pp. 165-175
-
-
Kariko, K.1
Buckstein, M.2
Ni, H.3
Weissman, D.4
-
45
-
-
77954350917
-
Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC
-
Salomon, W, Bulock, K, Lapierre, J, Pavco, P, Woolf, T and Kamens, J (2010). Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC. Nucleic Acids Res 38: 3771-3779.
-
(2010)
Nucleic Acids Res
, vol.38
, pp. 3771-3779
-
-
Salomon, W.1
Bulock, K.2
Lapierre, J.3
Pavco, P.4
Woolf, T.5
Kamens, J.6
-
46
-
-
0030272268
-
New carbamate supports for the preparation of 3'-amino-modified oligonucleotides
-
DOI 10.1016/0968-0896(96)00156-3, PII S0968089696001563
-
Aviñó, A, Güimil Garcia, R, Albericio, F, Mann, M, Wilm, M, Neubauer, G et al. (1996). New carbamate supports for the preparation of 3'-amino-modified oligonucleotides. Bioorg Med Chem 4: 1649-1658. (Pubitemid 26361869)
-
(1996)
Bioorganic and Medicinal Chemistry
, vol.4
, Issue.10
, pp. 1649-1658
-
-
Avino, A.1
Garcia, R.G.2
Albericio, F.3
Mann, M.4
Wilm, M.5
Neubauer, G.6
Eritja, R.7
-
47
-
-
0027224059
-
Clinicopathologic study of dextran sulfate sodium experimental murine colitis
-
Cooper, HS, Murthy, SN, Shah, RS and Sedergran, DJ (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249.
-
(1993)
Lab Invest
, vol.69
, pp. 238-249
-
-
Cooper, H.S.1
Murthy, S.N.2
Shah, R.S.3
Sedergran, D.J.4
-
48
-
-
0021742157
-
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models
-
Krawisz, JE, Sharon, P and Stenson, WF (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350. (Pubitemid 15201434)
-
(1984)
Gastroenterology
, vol.87
, Issue.6
, pp. 1344-1350
-
-
Krawisz, J.E.1
Sharon, P.2
Stenson, W.F.3
-
49
-
-
0031736096
-
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
-
DOI 10.1046/j.1365-2249.1998.00728.x
-
Dieleman, LA, Palmen, MJ, Akol, H, Bloemena, E, Peña, AS, Meuwissen, SG et al. (1998). Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114: 385-391. (Pubitemid 28539597)
-
(1998)
Clinical and Experimental Immunology
, vol.114
, Issue.3
, pp. 385-391
-
-
Dieleman, L.A.1
Palmen, M.J.H.J.2
Akol, H.3
Bloemena, E.4
Pena, A.S.5
Meuwissen, S.G.M.6
Van Rees, E.P.7
-
50
-
-
34248684162
-
Generesolution analysis of DNA copy number variation using oligonucleotide expression microarrays
-
Auer, H, Newsom, DL, Nowak, NJ, McHugh, KM, Singh, S, Yu, CY et al. (2007). Generesolution analysis of DNA copy number variation using oligonucleotide expression microarrays. BMC Genomics 8: 111.
-
(2007)
BMC Genomics
, vol.8
, pp. 111
-
-
Auer, H.1
Newsom, D.L.2
Nowak, N.J.3
McHugh, K.M.4
Singh, S.5
Yu, C.Y.6
|